MINI FUTURE SHORT - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 02:50:41 2024-07-17 am EDT | ||
| 2.16 EUR | +0.47% |
|
| Current month | -1.83% | ||
| 1 month | -2.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-07-17 | 2.16 | +0.47% |
| 24-07-16 | 2.15 | -4.02% |
| 24-07-15 | 2.24 | +1.82% |
| 24-07-12 | 2.2 | +0.46% |
| 24-07-11 | 2.19 | +0.92% |
Delayed Quote Deutsche Boerse AG
Last update July 17, 2024 at 02:50 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PN78KY |
| ISIN | DE000PN78KY1 |
| Date issued | 2023-09-08 |
| Strike | 64.38 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.32 € |
|---|---|
| Lowest since issue | 0.45 € |
| Spread | 0.01 € |
| Spread % | 0.46% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
52.69
USD
Spread / Average Target
+27.90%
- Stock Market
- Certificates
- Certificat
